90 related articles for article (PubMed ID: 9408734)
1. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences.
Gall MA
Dan Med Bull; 1997 Nov; 44(5):465-85. PubMed ID: 9408734
[No Abstract] [Full Text] [Related]
2. Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus.
Corradi L; Zoppi A; Tettamanti F; Malamani G; Lazzari P; Fogari R
J Hypertens Suppl; 1993 Dec; 11(5):S190-1. PubMed ID: 8158337
[No Abstract] [Full Text] [Related]
3. [Value of microalbuminuria determination in the non-insulin-dependent diabetic].
Ben Mami Ben Miled F; Blouza S; Abid A; Ben Hmida L; Ben Rayana MC; Nagati K
Tunis Med; 1994; 72(8-9):503-7. PubMed ID: 7716817
[No Abstract] [Full Text] [Related]
4. [Relationship between urinary albumin excretion and blood vessel lesion in non-insulin-dependent diabetics].
Long Z; Qu G; Jian Z; Mo Z
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):259-61. PubMed ID: 9868130
[TBL] [Abstract][Full Text] [Related]
5. [Microalbuminuria in diabetes mellitus. Evaluation of a latex agglutination test].
Gragnoli G; Tanganelli L; Signorini AM
Minerva Endocrinol; 1987; 12(2):143-7. PubMed ID: 3614168
[No Abstract] [Full Text] [Related]
6. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
Gorson DM
Diabetes Care; 1998 Dec; 21(12):2190-1. PubMed ID: 9839116
[No Abstract] [Full Text] [Related]
7. Microalbuminuria in non-insulin dependent diabetes mellitus.
Patel KL; Mhetras SB; Varthakavi PK; Merchant PC; Nihalani KD
J Assoc Physicians India; 1999 Jun; 47(6):596-601. PubMed ID: 10999155
[TBL] [Abstract][Full Text] [Related]
8. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
[No Abstract] [Full Text] [Related]
9. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
[TBL] [Abstract][Full Text] [Related]
10. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
Buranakitjaroen P; Deerochanawong C; Bunnag P
J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
[TBL] [Abstract][Full Text] [Related]
11. [Proteinuria in diabetes mellitus--a prognostic indicator even in type II?].
Janka HU
Dtsch Med Wochenschr; 1987 Sep; 112(38):1443-4. PubMed ID: 3622291
[No Abstract] [Full Text] [Related]
12. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH
Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO; Coll JR; Tran ZV; Schrier RW
Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
[TBL] [Abstract][Full Text] [Related]
14. [Screening for chronic kidney disease in patients with diabetes mellitus].
Kes P; Basić-Jukić N; Furić-Cunko V
Lijec Vjesn; 2010; 132(9-10):316-7. PubMed ID: 21261032
[No Abstract] [Full Text] [Related]
15. [Significant risk factors for development of microalbuminuria and diabetic nephropathy in patients with non-insulin-dependent diabetes].
Gall ML; Hougaard P; Borch-Johnsen K; Parving HH
Ugeskr Laeger; 1998 Jul; 160(31):4524-7. PubMed ID: 9700308
[TBL] [Abstract][Full Text] [Related]
16. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
Adetunji OR; Mani H; Olujohungbe A; Abraham KA; Gill GV
Diabetes Res Clin Pract; 2009 Aug; 85(2):179-82. PubMed ID: 19481284
[TBL] [Abstract][Full Text] [Related]
17. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
19. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
20. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
